Johnson & Johnson MedTech launches mobile simulator for breast procedures
January 16, 2026
Johnson & Johnson (NYSE: JNJ)+
announced that it launched the Arbrea Breast Simulator Surgeon App for Mentor in the U.S.
Johnson & Johnson (NYSE: JNJ)+
announced that it launched the Arbrea Breast Simulator Surgeon App for Mentor in the U.S.
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC is also more likely to metastasize, or travel through the bloodstream to spread to other organs, which causes most of breast cancer-related deaths each year.
BD (NYSE: BDX)+
announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue removal system.
IotaMotion announced today that it received FDA 510(k) clearance for expanded pediatric use of its iotaSoft insertion system.
A team of scientists from China has successfully created a miniature womb on a chip that mimics the complex environment of the human uterus. The research offers a new way to study the exact moment an embryo attaches to a mother’s body.
CMR Surgical announced today that it received CE mark and U.K. approval for its Versius surgical robot in pediatric surgery.
An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier.
Two pioneering, clinically-led digital app solutions have won the Ripple Women’s Digital Health Challenge – a global innovation programme, delivered by Cogniss in partnership with the Health Innovation Network (the Network) and Amazon Web Services (AWS).
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.
Abbott (NYSE: ABT)+
announced today that it received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo Occluder.